Nemvaleukin showed promising antitumor activity and manageable safety in advanced solid tumors, both alone and with pembrolizumab. ARTISTRY-1 study included dose-escalation, dose-expansion, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results